Madrigal Pharma (MDGL): FDA Approves rezdiffra

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Madrigal Pharma (MDGL): FDA Approves rezdiffra
(NASDAQ: MDGL) Delayed: 513.43 +0.55 (0.11%)
Previous Close $512.88    52 Week High $18.24 
Open $513.36    52 Week Low $6.60 
Day High $522.00    P/E N/A 
Day Low $507.57    EPS $0.00 
Volume 266,384